Founded in 1994 with a vision of increasing health care standards and expectations of quality of life for patients and continued product innovation and development, Allegra Orthopaedics Limited ( formerly known as Advanced Surgical Design and Manufacture Limited) has used its returns from operations over that period for research and development to broaden its product range and depth. In the field of primary knee replacement prostheses, its product the Active Knee, established amongst the leading designs in the Australian market according to the 2007 Australian Orthopaedic Association’s Joint Registry.

Differing variants have won orders in the United States of America (USA), Greece and the United Kingdom (UK). Our principal products have clinical histories in excess of fifteen or more years. In addition, the Company now receives revenues from consulting and design services as well as sales of medical devices. From its strong position and the extensive clinical history of its products, Allegra now has the opportunity to consolidate its position in the Australian market and target high value niche opportunities in the lucrative USA, UK and key European markets.


Allegra has used its expertise in developing and commercialising medical devices to generate a pipeline of new products at various stages of development, including range extensions of its current product family that strengthen its appeal to a broader audience of orthopaedic surgeons. In addition, Allegra leverages its research, development, manufacturing and clinical trial capabilities to prototype and build clinical histories of a number of exciting and innovative medical devices.

One of Allegra’s core competencies is collaborative development which is evidenced by the appointment as exclusive manufacturer of All Vascular Pty Limited’s Peripheral Access device (PAD). Allegra is currently project managing the development and clinical trial of the device in the field of vascular surgery. The Company has built a portfolio of promising research collaborations with companies, university research groups and surgeon inventor/innovators. These collaborations are yielding new orthopaedic and medical device innovations that may see commercialisation over the next several years.

Allegra has built capabilities in the design, prototyping and manufacture of medical devices and implants that have been fully certified to TGA, EU/CE and FDA standards. The most strategic elements of the design and manufacturing capacity have been built in-house, whilst less strategic elements of the fabrication process are outsourced